✦ LIBER ✦

Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands

✍ Scribed by Anne M. van Altena; Henrike E. Karim-Kos; Esther de Vries; Roy F.P.M. Kruitwagen; Leon F.A.G. Massuger; Lambertus A. Kiemeney

Book ID: 113964083
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 290 KB
Volume: 125
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.02.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trends in treatment of advanced epitheli

Trends in treatment of advanced epithelial ovarian cancer in the Medicare population

✍ Melissa M. Thrall; Heidi J. Gray; Rebecca Gaston Symons; Noel S. Weiss; David R. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 649 KB

Trends in treatment of advanced epitheli

Trends in treatment of advanced epithelial ovarian cancer in the Medicare population

✍ Maurie Markman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Stage-specific survival of epithelial ca

Stage-specific survival of epithelial cancers in North-Holland/Flevoland, The Netherlands

✍ O. Visser; F.E. van Leeuwen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 555 KB

The Effect of Bowel Resection on Surviva

The Effect of Bowel Resection on Survival in Advanced Epithelial Ovarian Cancer

✍ W. Jaeger; S. Ackermann; H. Kessler; A. Katalinic; N. Lang 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Stage- and CA125–related survival in pat

Stage- and CA125–related survival in patients with epithelial ovarian cancer treated at a cancer center

✍ R.E. BOARD; C.T.P.H. BRUIJNS; A.E. PRONK; W.D.J. RYDER; P.M. WILKINSON; R. WELCH 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Plasminogen activator inhibitor-1 is an

Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

✍ Setsuko K. Chambers; Christina M. Ivins; Maria L. Carcangiu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB 👁 2 views

High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Reports, however, on the prognostic value of PAI-1 co